4,4'-((6-((2-Aminoethyl)amino)-1,3,5-triazine-2,4-diyl)bis(azanediyl))bis(butan-1-ol)

Catalog No. :
ACCNWG302
CAS No. :
2757730-53-1
Molecular Formula :
C13H27N7O2
Molecular Weight :
313.41

IUPAC Name:4,4'-((6-((2-aminoethyl)amino)-1,3,5-triazine-2,4-diyl)bis(azanediyl))bis(butan-1-ol)

4,4'-((6-((2-Aminoethyl)amino)-1,3,5-triazine-2,4-diyl)bis(azanediyl))bis(butan-1-ol) structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
50mg97%$56.00Login to see priceIn stockInquiry
100mg97%$91.00Login to see priceIn stockInquiry
250mg97%$135.00Login to see priceInquiryInquiry
1g97%$336.00Login to see priceInquiryInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Name4,4'-((6-((2-Aminoethyl)amino)-1,3,5-triazine-2,4-diyl)bis(azanediyl))bis(butan-1-ol)
IUPAC Name4,4'-((6-((2-aminoethyl)amino)-1,3,5-triazine-2,4-diyl)bis(azanediyl))bis(butan-1-ol)
Molecular FormulaC13H27N7O2
Molecular Weight313.41
SMILESNCCNC1=NC(NCCCCO)=NC(NCCCCO)=N1
InChI KeyBGIDHSGFEYYFLH-UHFFFAOYSA-N
Synonym4,4'-((6-((2-Aminoethyl)amino)-1,3,5-triazine-2,4-diyl)bis(azanediyl))bis(butan-1-ol)
CAS No.2757730-53-1

Safety Data

Pictogram
Harmful or irritant
Signal Word
Achtung
Hazard Statement(s)
H315-H319
Precautionary Statement(s)
P264-P280-P302+P352-P305+P351+P338-P332+P313-P337+P313-P362+P364

Synthetic Route by SureRoute

1. ACCNWG302 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACDOKV094 route compound structure diagram
    ACDOKV09416483-18-4 In Stock
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACCNWG302 route product structure diagram
    ACCNWG3022757730-53-1 In Stock
Inquiry

2. ACCNWG302 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Then
  3. ACCNWG302 route product structure diagram
    ACCNWG3022757730-53-1 In Stock
Inquiry

Comments (0)